Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
Todd W. Miller(Dartmouth College), Carlos L. Arteaga(The University of Texas Southwestern Medical Center)
Cited by 463
Related Papers
Association with HSP90 Inhibits Cbl-Mediated Down-regulation of Mutant Epidermal Growth Factor Receptors
|Cancer Research|2006|79
Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells
|Breast Cancer Research|2014|77
Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
|Cancer Immunology Research|2022|59
Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer
|Nature Communications|2020|52
Proapoptotic Activity of Cell-Permeable Anti-Akt Single-Chain Antibodies
|Cancer Research|2005|50